| Company Name: | ArthroCare Corporation | | Ticker Symbol: | ARTC | | | WWW Address: | www.arthrocare.com |
| CEO: | David Fitzgerald | | No. of Employees: | 1,700 |
| Common Issue Type: | CS | | Business Description: | ArthroCare Corporation a multi-business medical device company that develops, manufactures and markets invasive surgical products.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 34.67 |  0.22 | 31.41 | 37.94 | 34.68 | 35.09 | 34.23 | 160474 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 977.7 | 28.2 | 1.46 | 1.25 | 0.00 | 28.9 | 0.0 | 36.99 - 24.37 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 34.65 | $ | | PE Ratio - LTM | 28.9 | |
| Market Capitalisation | 977.7 | mil |
| Latest Shares Outstanding | 28.2 | mil |
| Earnings pS (EPS) | 1.25 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 216,738 | $ |
| Effective Tax Rate | 27.2 | % |
| Float | 27.8 | mil |
| Float as % of Shares Outstanding | 98.5 | % |
| Foreign Sales | 122 | mil |
| Domestic Sales | 229 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 43.80 | % |
| Research & Devlopment (R&D) as % of Revenue | 9.00 | % |
| Gross Profit Margin | 74.3 | % |
| EBITDA Margin | 21.6 | % |
| Pre-Tax Profit Margin | 16.3 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | 8.4 | % |
| Return on Equity (ROE) | 11.8 | % |
| Return on Capital Invested (ROCI) | 11.8 | % |
| Current Ratio | 7.1 | |
| Leverage Ratio (Assets/Equity) | 1.4 | |
| Interest Cover | 71.7 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 10.54 | $ |
| Cash pS | 8.16 | $ |
| Book-Value pS | 13.40 | $ |
| Tangible Book-Value pS | 8.74 | $ |
| Cash Flow pS | 2.13 | $ |
| Free Cash Flow pS | 2.20 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.59 | |
| Price/Tangible Book Ratio | 3.97 | |
| Price/Cash Flow | 16.3 | |
| Price/Free Cash Flow | 15.7 | |
| P/E as % of Industry Group | 136.0 | % |
| P/E as % of Sector Segment | 105.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.6 | 97 | 1,721 | 8,758 |
| 4 Weeks | 35.22 | 32.89 | 33.84 | 2.4 | 96 | 1,269 | 25,387 |
| 13 Weeks | 36.83 | 32.76 | 36.32 | -4.6 | 87 | 1,092 | 68,785 |
| 26 Weeks | 36.99 | 30.47 | 31.79 | 9.0 | 89 | 1,088 | 134,898 |
| 52 Weeks | 36.99 | 24.37 | 24.80 | 39.7 | 109 | 1,315 | 327,340 |
| YTD | 36.99 | 32.76 | - | 0.2 | 86 | 1,023 | 97,160 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 34.73 | 34.49 | 34.53 | 34.31 | 33.19 | 1.46 | 0.36 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 2.65 | 71.7 | 1.70 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -25.14 | NA | -9.03 |
| R&D | 0.82 | NA | -4.15 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -0.6 | -0.6 | 3.8 |
| Earnings % | -13.7 | -13.7 | 0.0 |
| EPS % | -16.7 | -16.7 | 0.0 |
| EPS $ | -0.06 | -0.06 | 1.48 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 55.36 |
| Current Ratio | 6.3 |
| Quick Ratio (Acid Test) | 4.9 |
| Liquidity Ratio (Cash) | 4.02 |
| Receivables Turnover | 7.4 |
| Average Collection Period | 49 |
| Working Capital/Equity | 79.0 |
| Working Capital pS | 10.28 |
| Cash-Flow pS | 2.26 |
| Free Cash-Flow pS | -0.20 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.65 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 30.0 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 27.8 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 76.1 |
| Interest/Capital Invested | 0.18 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.29 |
| Tobin's Q Ratio | 1.88 |
| Current P/E Ratio - LTM | 28.90 |
| Enterprise Value (EV)/EBITDA | 10.81 |
| Enterprise Value (EV)/Free Cash Flow | -205.99 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.97 |
| Price/Book Ratio - LTM | 2.59 |
| Price/Cash Flow Ratio | 16.3 |
| Price/Free Cash Flow Ratio - LTM | 15.7 |
| Price/Sales Ratio | 2.66 |
| P/E Ratio (1 month ago) - LTM | 27.7 |
| P/E Ratio (26 weeks ago) - LTM | 529.8 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 136.0 |
| P/E as % of Sector Segment | 105.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 28.9 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.95 |
| Tangible Book Value pS - LTM | 8.74 |
| Book Value pS - LTM | 13.40 |
| Capital Invested pS | 12.91 |
| Cash pS - LTM | 8.16 |
| Cash Flow pS - LTM | 2.13 |
| Free Cash Flow pS - LTM | 2.20 |
| Earnings pS (EPS) | 1.25 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -1.48 |
| Free Cash Flow Margin 5YEAR AVG | 8.37 |
| Net Profit Margin | 12.6 |
| Net Profit Margin - 5YEAR AVRG. | 2.4 |
| Equity Productivity | 1.01 |
| Return on Equity (ROE) | 12.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 2.9 |
| Capital Invested Productivity | 1.01 |
| Return on Capital Invested (ROCI) | 12.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 2.9 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | 8.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.9 |
| Gross Profit Margin | 74.3 |
| Gross Profit Margin - 5YEAR AVRG. | 75.5 |
| EBITDA Margin - LTM | 21.6 |
| EBIT Margin - LTM | 16.5 |
| Pre-Tax Profit Margin | 17.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 3.0 |
| Effective Tax Rate | 27.2 |
| Effective Tax Rate - 5YEAR AVRG. | 11.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 212 |
| Revenue per Employee | 216,738 |
| Net Income per Employee | 27,281 |
| Average Collection Period | 48 |
| Receivables Turnover | 7.4 |
| Day's Inventory Turnover Ratio | 164 |
| Inventory Turnover | 2.2 |
| Inventory/Sales | 13.1 |
| Accounts Payble/Sales | 3.31 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 1.28 |
| Fixed Assets Turnover | 2.07 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 1.68 |
| Revenue per $ Plant | 12.10 |
| Revenue per $ Common Equity | 1.01 |
| Revenue per $ Capital Invested | 1.01 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 43.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 54.3 |
| Research & Devlopment (R&D) as % of Revenue | 8.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 8.7 |
|
|  
|
| |
 |  |
